ReviewGenes & diseases2023

Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients.

Sunny Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.